Joshua S. Jacobs

基本信息

浏览量：154

职业迁徙

个人简介

Dr. Jacob’s areas of interest are the treatment of hereditary angioedema, chronic sinusitis, atopic dermatitis/food allergy, asthma and primary immunodeficiency.

研究兴趣

论文共 61 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Garadacimab for Hereditary Angioedema Prophylaxis in Adolescents: Efficacy and Safety from the Phase 3 (VANGUARD) Study and Open-Label Extension (second Interim Analysis)

Joshua Jacobs,Markus Magerl,Inmaculada Martinez-Saguer,Huamin Li,Jonathan Bernstein,Connie Hsu,Karl Sitz,Lolis Wieman,Henrike Feuer-Senger, Maressa Pollen,Avner Reshef

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): AB6-AB6

引用0浏览0引用

Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps

Joshua S. Jacobs,Joseph K. Han,Jason K. Lee,Tanya M. Laidlaw, Nicole L. Martin,Scott Caveney,Christopher S. Ambrose,Neil Martin,Joseph D. Spahn,Flavia C. L. Hoyte

Advances in Therapypp.1-13, (2024)

引用0浏览0WOS引用

The Utility of Shared Decision Making in the Management of Hereditary Angioedema

Rachel Odin,John Anderson,Joshua Jacobs, Douglas Jones,H. Henry Li,William Lumry,Michael Manning,Daniel Soteres,Raffi Tachdjian,William Yang,Jonathan A. Bernstein

ALLERGY AND ASTHMA PROCEEDINGSno. 6 (2024): 434-437

引用0浏览0WOS引用

Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis Across 3 Clinical Trials: Phase 2, Pivotal Phase 3, and Open-Label Extension Studies

M. Magerl,T. J. Craig,J. Anderson,J. S. Jacobs,R. Tachdjian,H. Farkas,W. H. Yang,P. Staubach,E. Aygoeren-Puersuen,I. Ohsawa, M. Pollen,J. -P. Lawo, M. A. Bica,I. Jacobs

ALLERGOLOGIEno. 9 (2024)

引用0浏览0引用

Approach to Identification of Patients with Activated Phosphoinositide-3 Kinase Delta Syndrome (APDS)

Daniel Suez,Richard Wasserman,Amy Darter,Elena Perez,Joshua Jacobs,Dareen Siri, David Patterson, Jacob Offenberger,William Lumry,Mark Scarupa

Journal of Allergy and Clinical Immunologyno. 2 (2023): AB81-AB81

引用0浏览0引用

Tezepelumab Efficacy by SNOT-22 Score in Patients with Severe, Uncontrolled Asthma and Comorbid Nasal Polyps in NAVIGATOR

Joshua Jacobs,Flavia Hoyte,Joseph Spahn,Chris Ambrose,Nicole Martin, Sylvia Vong,Scott Caveney,Bill Cook,Gene Colice

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2023）

引用2浏览0引用

REMIBRUTINIB PROVIDES FAST AND CLINICALLY IMPORTANT IMPROVEMENT OF CHRONIC SPONTANEOUS URTICARIA DISEASE ACTIVITY

J. Jacobs,M. Maurer,A. Gimenez-Arnau,S. Savic,C. Ortmann, B. Suryawanshi,I. Nikolaev,S. Haemmerle

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGYno. 5 (2023): S34-S35

引用0浏览0引用

Efficacy and Safety of Lanadelumab in Pediatric Patients with Hereditary Angioedema Aged 2 to < 12 Years: Results of the Open-Label, Multi-Centric Phase 3 SPRING Study

M. Kappek,M. Maurer,W. R. Lumry,H. H. Li, E. Aygoeren-Pursun,P. Busse,J. Jacobs,C. Nurse

ALLERGOLOGIE（2023）

引用0浏览0引用

Maureen Watt,Marcus Maurer,William Lumry,H. Henry Li,Emel Aygoeren-Puersuen,Paula Busse,Joshua Jacobs,Christina Nurse,Ming Yu,Dorothy Romanus,Giovanna Devercelli

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2023): AB139-AB139

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Medical Director

论文共 61 篇作者统计合作学者相似作者